The androgen receptor (AR) signaling pathway is a common therapeutic target for prostate cancer, because it is critical for the survival of both hormone-responsive and castrate-resistant tumor cells. Most of the detailed understanding that we have of AR transcriptional activation has been gained by studying classical target genes. For more than two decades, Kallikrein 3 (KLK3) (prostate-specific antigen) has been used as a prototypical AR target gene, because it is highly androgen responsive in prostate cancer cells. Three regions upstream of the KLK3 gene, including the distal enhancer, are known to contain consensus androgen-responsive elements required for AR-mediated transcriptional activation. Here, we show that KLK3 is one of a specific cluster of androgen-regulated genes at the centromeric end of the kallikrein locus with enhancers that evolved from the long terminal repeat (LTR) (LTR40a) of an endogenous retrovirus. Ligand-dependent recruitment of the AR to individual LTR-derived enhancers results in concurrent up-regulation of endogenous KLK2, KLK3, and KLKP1 expression in LNCaP prostate cancer cells. At the molecular level, a kallikreinspecific duplication within the LTR is required for maximal androgen responsiveness. Therefore, KLK3 represents a subset of target genes regulated by repetitive elements but is not typical of the whole spectrum of androgen-responsive transcripts. These data provide a novel and more detailed understanding of AR transcriptional activation and emphasize the importance of repetitive elements as functional regulatory units. (Endocrinology 153: 3199 -3210, 2012) 
K allikrein 3 (KLK3) is commonly known as prostatespecific antigen and is among the most well-characterized human genes. Not only is KLK3 the current serum biomarker for prostate cancer, but, as a classical androgen receptor (AR) target gene, it is frequently used as a model to study androgen signaling in prostate epithelial cells (1, 2) . A detailed understanding of KLK3 expression has emerged as a result of intense interest in the actions of the AR, the most common therapeutic target in advanced prostate cancer (3) . However, the insights into KLK3 regulation cannot always be extrapolated to other known target genes or be easily used to identify novel AR-regulated transcripts. Indeed, rather than being the quintessential AR target gene, it is possible that KLK3 represents a subset of genes sharing as yet unknown characteristics.
The core structure of the KLK3 gene was first described in the 1990s. The proximal promoter contains two androgen response elements (ARE), AREI (Ϫ156 bp) and AREII (Ϫ400 bp), which are sufficient for moderate levels of androgen-regulated gene expression (4 -6) . The KLK3 enhancer contains a deoxyribonuclease (DNase) I-sensitive region from Ϫ3738 to Ϫ5824 bp and is required for maximal prostate-specific gene expression (7) (8) (9) . The enhancer contains AREIII (Ϫ4134), five nonconsensus accessory ARE, and binding sites for AR coactivators, such as forkhead box protein A1 (FoxA1) and GATA binding protein 2 (GATA2) (10 -12) . Since these regions were first identified, more than 90 factors have been shown to directly affect the androgen-regulated expression of KLK3 (1) . The epigenetic marks and chromatin structure associated with active KLK3 expression have also been defined (13) (14) (15) .
One aspect of KLK3 expression that is sometimes overlooked is that it is surrounded by other hormone-regulated genes. KLK3 is part of the KLK family of 15 serine peptidases, the largest contiguous gene family in the human genome (1) . KLK2, which lies adjacent to KLK3, is also a well-known AR target gene. KLK3 arose through duplication of KLK2, so both genes are regulated through similar mechanisms (16) . The AR-binding sites are conserved, and the broader KLK2 and KLK3 promoter and enhancer regions share over 80% sequence identity (17, 18) . Separate studies have shown that other KLK genes, including KLK4 and KLK15, are also androgen regulated in prostate epithelial cells (19 -23) . No AR-binding sites have been identified for these genes, although an indirect ARbinding region has been reported for KLK4 (20) . Most recently, our laboratory and others cloned a kallikreinlike gene, Kallikrein pseudogene 1 (KLKP1), which is also up-regulated by androgens (24 -26). The KLKP1 gene consists of a region that is similar to intron 1 to intron 2 of KLK1, KLK2, and KLK3, as well as three "exonized" repeats. None of the four transcripts arising from KLKP1 encode a serine peptidase, although at least one transcript, KRIP1, is known to be translated (24).
The discovery of yet another androgen-regulated gene in the KLK locus prompted us to reexamine the prostatic expression and androgen responsiveness of this family in more detail and determine whether they are typical or atypical AR target genes. When we compared the levels of all 16 genes across a range of prostate cell lines, we observed that a discrete cluster of genes, KLK2, KLK3, KLK4, KLK15, and KLKP1, are consistently coexpressed in cells with a luminal phenotype (1) . In this study, we detail how all of the KLK genes in this cluster are direct AR target genes. We also show that the well-characterized KLK2 and KLK3 enhancers, and a novel AR-binding region within KLKP1, are derived from a specific repetitive element, LTR40a, the long terminal repeat (LTR) of an endogenous retrovirus (27). These findings shed light on the origins of androgen-responsive enhancers in the KLK locus, imply that similar mechanisms regulate these genes and endogenous retroviruses, and suggest that repetitive elements comprise an important subset of AR-binding sites.
Materials and Methods

Cell culture
LNCaP, 22Rv1, C4-2B, and DU145 prostate cancer cell lines were obtained from the American Type Culture Collection (Manassas, VA). All cells were routinely cultured in RPMI 1640 medium (Invitrogen, Mount Waverly, Victoria, Australia) containing 10% fetal calf serum (Invitrogen), 50 U/ml penicillin G, and 50 ug/ml streptomycin (Invitrogen). Before androgen treatments, cells were cultured in phenol red-free RPMI 1640 with 10% charcoal-stripped serum (CSS) for 72 h. Unless otherwise stated, cells were then treated with 1 nM R1881 (PerkinElmer, Boston, MA) or ethanol as a control for 24 h. For bicalutamide experiments, cells were pretreated with 0 -100 M bicalutamide (Astra Zeneca, Brisbane, Queensland, Australia) for 2 h and then cultured for an additional 24 h with 1 nM R1881 and the same concentration of bicalutamide.
AR knockdown
LNCaP cells were seeded at 1 ϫ 10 5 cells per well in six-well plates, grown to 30% confluence over 48 h, and then cultured in antibiotic-free medium with 10% CSS for 72 h. Cells were transfected with 100 nM of previously described (13) small interfering RNA (siRNA) for AR or a nontargeting control (Sigma-Proligo, Sydney, New South Wales, Australia) using oligofectamine (Invitrogen) . Approximately 48 h after transfection, cells were treated with 1 nM R1881 or ethanol control for 48 h.
RNA extractions and quantitative RT-PCR (qPCR)
Total RNA was extracted using TRIzol, treated with DNase I, and reverse transcribed with SuperScript III according to the manufacturer's instructions (Invitrogen). qPCR was conducted using ABI PRISM 7000, 7300, and 7900 thermocyclers and SYBR Green PCR Master Mix (Applied Biosystems, Scoresby, Victoria, Australia). The sequences of all primers are listed in the Supplemental Table 1 , published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org. Relative gene expression compared with a control sample was determined using the comparative threshold cycle (⌬⌬C T ) method with glyceraldehyde 3-phosphate dehydrogenase, hypoxanthine phosphoribosyltransferase 1, or 18S as the housekeeping gene. To calculate absolute numbers of transcripts, samples were compared with standard curves of PCR products cloned into pGEM-T Easy (Promega, Alexandria, New South Wales, Australia).
Chromatin immunoprecipitation (ChIP) assay
C4-2B cells were cultured in media containing 5% CSS for 48 h and then treated with 10 nM dihydrotestosterone (DHT) or ethanol for 4 h. Samples were then processed as previously described (28). Immunoprecipitations were performed with 4 g of a rabbit antihuman AR antibody (N-20; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or normal rabbit IgG (Santa Cruz Biotechnology, Inc.) at 4 C overnight. Samples were analyzed using qPCR with 5 l of DNA, iQ SYBR Green supermix (BioRad Laboratories, Gladesville, New South Wales, Australia), and 4 m of primers, which are listed in Supplemental Table 2 . Cycling parameters were 95 C for 3 min and then 55 cycles at 95 C for 15 sec, 60 C for 15 sec, and 72 C for 30 sec. All reactions were followed by melt curve analysis to confirm the specificity of the amplified products.
Supplemental Table 3 . Purified PCR products were cloned into the pGEMT-Easy vector (Promega) and then subcloned into the pGL3 promoter vector (Promega) using XhoI restriction sites. KLK3 and KLKP1-T deletion constructs were amplified from vectors containing the full-length LTR using the primers listed in Supplemental Table 4 . All inserts were sequenced at the Australian Genome Research Facility (Brisbane, Australia). For luciferase assays, 1.5 ϫ 10 5 LNCaP cells were seeded per well in 24-well plates, grown for 48 h, and then cultured in media with 10% CSS for 72 h. Lipofectamine 2000 (Invitrogen) was used to transfect the cells in each well with 300 ng of Renilla and equimolar amounts of each pGL3 construct, equivalent to 500 ng of the empty vector. The media were replaced after 6 h, and the cells were treated with ethanol or 1 nM R1881 for 24 h. Luminescence was measured using the Dual-Luciferase Reporter Assay System (Promega) on a PolarStar plate reader (BMG, Labtech, Offenburg, Germany).
Statistical analysis
GraphPad Prism was used for statistical analyses (GraphPad, La Jolla, CA). All error bars represent the SEM of biological replicates performed on separate occasions. For all figures, P values are represented as three-point star for P Ͻ 0.05, four-point star for P Ͻ 0.01, and asterisk for P Ͻ 0.001.
Results
The centromeric cluster of KLK genes is androgen regulated
A group of KLK genes at the centromeric end of the locus are coordinately expressed in androgen-responsive prostate cell lines, whereas KLK genes outside this cluster are expressed in cell lines with little or no sensitivity to androgens (1) . To determine whether this dichotomy is due to differences in androgen-regulated gene expression, we examined the expression of the entire KLK locus in prostate cells treated with R1881, a synthetic, nonmetabolizable androgen. In androgen-dependent LNCaP cells, the centromeric genes, KLK15, KLK3, KLK2, KLKP1, and KLK4, were all significantly up-regulated by R1881 (Fig. 1A) . The expression levels of other KLK genes were below the detection limit, except for KLK14, which was down-regulated by R1881 treatment as we have previously reported (29). R1881 treatment also increased the levels of KLK15, KLK2, KLK3, and KLK4 protein in LNCaP-conditioned media (Supplemental Fig. 1A ). The same trend in KLK expression was observed in the castrateresistant C4-2B subline of LNCaP cells (Fig. 1B) . In 22Rv1 cells, which are also castrate-resistant but androgen-sensitive, R1881 treatment once again induced significant increases in KLK15, KLK3, KLK2, KLKP1, and KLK4 expression (Fig. 1C ). KLK1 and KLK10 were also upregulated, but both genes are expressed at relatively low levels (Supplemental Fig. 1 , B and C). To understand the differences in fold changes between genes, we also measured the absolute levels of KLK transcripts (Supplemental Fig. 1 , B and C). The larger fold changes for KLK2 and KLK3 are due to lower expression in the absence of R1881 compared with other KLK genes. Collectively, as the first complete profile of gene expression in the KLK locus, these data demonstrate that KLK3 and other KLK genes form a discrete cluster of androgen-regulated genes.
The centromeric KLK are direct AR target genes
We next compared the kinetics of KLK2, KLK3, KLK4, KLK15, and KLKP1 expression, which suggested that they are all directly regulated by the AR. In dose-response experiments, all genes were significantly up-regulated by treatment with 1 and 10 nM R1881 ( Fig. 2A) . Therefore, 1 nM R1881 was used for all subsequent experiments. In . Average log2 fluorescence values were normalized to ethanol controls. Data were averaged for genes with more than one probe (KLK3, KLK10, and KLK11). C, KLK gene expression in 22Rv1 cells treated and analyzed as per A. Data were analyzed using t tests (three-point star, P Ͻ 0.05; four-point star, P Ͻ 0.01; asterisk, P Ͻ 0.001, n ϭ 3 for LNCaP, n ϭ 5 for 22Rv1). EtOH, Ethanol. Endocrinology, July 2012, 153 (7):3199 -3210 endo.endojournals.orga time course of R1881 treatment, KLK expression began to increase by 6 h, with significant changes at 24 h (Fig.  2B ). In contrast, basal KLK expression significantly decreased in LNCaP cells that were deprived of androgens by being cultured in medium containing CSS (Fig. 2C) . To confirm the specificity of these responses, LNCaP cells were treated with R1881 and increasing concentrations of the AR antagonist, bicalutamide. KLK2, KLK3, and KLK4 expression was significantly down-regulated by 10 M bicalutamide and KLK15 and KLKP1 expression by 50 M bicalutamide (Fig. 2D ). The expression of all genes reverted to basal levels in cells treated with 100 M bicalutamide. Finally, the AR was knocked down with siRNA to verify that the KLK genes are direct target genes. ARspecific siRNA significantly reduced the levels of AR compared with the nontargeting control (Supplemental Fig. 2 ). In turn, this significantly decreased the androgen-regulated expression of KLK2, KLK3, KLK4, KLK15, and KLKP1 (Fig. 2E ). These data suggest that all KLK genes in the centromeric cluster are likely to be direct AR target genes. (Fig. 3, A and B) . Recruitment of the AR to the enhancer and proximal promoter of KLK2 was also observed (Fig. 3A) . A novel ARbinding region within the KLKP1 gene was also detected in both datasets (Fig. 3, A and C) . Intriguingly, this novel region and the KLK2 and KLK3 enhancers all contain a specific repetitive element, LTR40a, the LTR of a defunct endogenous retrovirus. Indeed, the DNase I-sensitive region of the KLK3 enhancer originally identified by Cleutjens et al. (8) falls almost entirely within an LTR40a element (Fig. 3B) . The presence of a repetitive element was 
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also noted by Olsson et al. (16, 32) . There are five copies of LTR40a in the KLK locus: one upstream of KLK15, one each overlapping with the KLK2 and KLK3 enhancers, and two within the KLKP1 gene (Fig. 3D) . We have designated the elements within KLKP1 as the centromeric (KLKP1-C) and telomeric (KLKP1-T) repeats. The ARbinding regions from the ChIP-on-chip studies overlap the telomeric element. The centromeric LTR40a element is split by an AluJr repeat. LTR40a elements also lie in syntenic regions of other mammalian genomes, including the macaque, marmoset, dog, and horse, which all have KLK2-and KLK3-related genes that are known to be expressed in the prostate (Supplemental Fig. 3 ). The KLK2 enhancer region, and therefore the corresponding LTR40a element, is deleted in the macaque, where KLK2 is a pseudogene. No LTR40a elements are present in the   FIG. 3 . AR-binding regions in the KLK locus overlap with LTR40a elements. A, AR-binding sites from two ChIP-on-chip datasets aligned to the KLK locus using the UCSC genome browser (hg18). The shaded regions are shown in greater detail for KLK3 (B) and KLKP1 (C). D, The location of all LTR40a elements (arrows) within the KLK locus, including the KLKP1-C element, which is split by an AluJr repeat. The location of repetitive elements from RepeatMasker is shown. SINE, Short interspersed nuclear elements; LINE, long interspersed nuclear elements; DNA, DNA repeat elements; Simple, simple repeats (microsatellites); low complexity, low complexity repeats; Satellite, satellite repeats; TSS, transcription start site.
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KLK loci of the mouse, rat, or cow, which all lack functional KLK2-related homologues.
LTR40a elements are androgen-responsive enhancers
Because LTR control retroviral gene expression, often in response to hormones, we hypothesized that the LTR40a elements may act as androgen-regulated enhancers for the centromeric group of KLK genes. To determine whether the AR is recruited to the LTR40a elements, as implied by the ChIP-on-chip data, we performed independent ChIP assays. These data showed that the AR occupies the KLK15, KLK3, KLK2, and KLKP1-T LTR40a elements in basal conditions (ethanol treatment) and that further recruitment is stimulated by androgens (Fig. 4A) . There was no androgen-induced recruitment of the AR to the KLKP1-C element, which is interrupted by an Alu repeat.
Given the recruitment of endogenous AR to the LTR40a elements, we next examined whether they are sufficient to induce androgen-regulated gene expression in luciferase assays with the pGL3 promoter vector. The five LTR40a elements lie in different orientations to their closest KLK genes. Therefore, they were all cloned in both the forward and inverse orientation to determine whether this alters luciferase activity. The KLK3, KLK2, and KLKP1-T LTR40a elements mediated androgen-responsive gene expression, as measured by luciferase activity, in both LNCaP and C4-2B cells treated with R1881 (Fig. 4, B and C) . The KLKP1-T repeat was more potent in its inverse orientation, whereas there was little difference between the forward and inverted constructs for KLK2 and KLK3. Although ChIP assays showed that the AR binds to the KLK15 repeat, it was not sufficient to induce androgenregulated activation of the region cloned into the reporter construct. The cloned KLKP1-C repeat was similarly nonfunctional. Collectively, these data demonstrate that LTR40a elements can act as androgen-responsive enhancers.
The LTR40a elements in the KLK locus have a unique duplication
To further characterize the LTR40a elements in the KLK locus, we aligned them to the consensus LTR40a sequence from Repbase (27). This showed that the five LTR40a elements have an insertion of approximately 95 bp ( Supplemental Fig. 4) . The alignment between the KLK3 LTR40a element and the consensus sequence is shown in Fig. 5 . Notably, the insertion contains AREIII, in addition to an accessory ARE, AREIV (33), and known binding sites for GATA2 and FOXA1 (10 -12), two collaborating transcription factors. Closer inspection of this region revealed that it is actually a duplication of an adjacent segment of the LTR, which contains AREIIIA, and GATA and FOXA1 sites in equivalent positions. The sequence varies at the site corresponding to AREIII; it is an additional GATA motif instead. We have designated the "inserted" region as Duplicate 1 (Fig. 5, yellow) and the related segment as Duplicate 2 (Fig. 5, red) . Further analysis of the KLK3 LTR40a element with Spectral Repeat Finder, a program that identifies repetitive DNA se- 
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Lawrence et al. LTR as KLK Enhancers Endocrinology, July 2012, 153(7):3199 -3210 quences (34), showed that the LTR is even more complex, with multiple smaller duplications (Supplemental Fig. 4 , blue and green) and a palindromic region (Supplemental Fig. 4, purple) .
To determine the contribution of each Duplicate to androgen-responsive gene expression, we prepared a series of reporter deletion constructs of the KLK3 and KLKP1-T elements, which had the greatest activity in luciferase assays (Fig. 6A) . We removed the Duplicates individually or together and also deleted the core ARE for comparison. The sequence of the novel KLKP1-T ARE (GGAACAtac-TATATT) was deduced from sequence alignments with the well-characterized KLK3 AREIII (GGAACAtatTG-TATC) (Supplemental Fig. 5 ). Each region was also cloned alone, without the surrounding LTR sequence. As previously observed, the full-length constructs (LTR) were activated by R1881 treatment of LNCaP cells (Fig. 6, B and  C) . Deletion of the ARE significantly decreased, but did not eliminate, the androgen responsiveness of the KLK3 and KLKP1-T LTR (Fig. 6 , B and C). Neither ARE alone was sufficient to induce luciferase expression above the background control (pGL3). The Duplicates make different contributions to the activity of the KLK3 enhancer compared with the KLKP1-T LTR. For KLK3, deletion of either Duplicate completely abolished the androgen responsiveness of the LTR. Duplicate 1, which contains AREIII, was not sufficient to regain enhancer activity. Duplicate 2 is moderately androgen responsive but only when present alone and not in the ⌬AREIII or ⌬D1 constructs, suggesting that surrounding regions of the LTR dampen its androgen responsiveness. This is overcome when Duplicate 1 (containing AREIII) and Duplicate 2 are combined, because they have similar activity to the full-length KLK3 LTR. The results were different for the KLKP1-T element. Deletion of either Duplicate reduces, but does not eliminate, androgen responsiveness. Unlike the KLK3 LTR, the KLKP1-T Duplicates alone are not androgen responsive, suggesting that the surrounding LTR sequences are also necessary. It is clear that cooperation between multiple complex elements is essential for maximal androgen responsiveness. These results imply that the internal duplication was an important step in the evolution of androgen responsiveness of the LTR40a elements and the formation of effective androgen-responsive enhancers in this locus.
Discussion
Traces of retroviral infections are spread throughout the human genome. Exogenous retroviruses become heritable when they integrate into the genome of germ cells (35). As endogenous retroviruses, they may then be copied through retrotransposition or genome rearrangements like duplications. Some endogenous retroviruses are still actively expressed in humans (35). Most, however, are not transcribed, and many have been deleted through homologous recombination, only leaving behind their LTR. Indeed, of the 450,000 LTR in the human genome, about 85% are solitary LTR without matching retroviral genes (36). Nevertheless, solitary LTR can still have important functions; they contain all the necessary transcription factor binding sites to drive retroviral gene expression, so can act as "ready-made" regulatory elements to reinforce or modify the expression of existing genes (37). This is the case for KLK3, which has been used as a model AR target gene for more than 15 yr. In this study, we demonstrate that the KLK3 enhancer is derived from an LTR40a element, as are AR-binding sites for KLK2 and KLKP1. Further analysis of these elements revealed an internal duplication that is unique to the KLK locus and is essential for maximal androgen-regulated gene expression. Therefore, the androgen responsiveness of KLK3 and other KLK genes is due to the fortuitous insertion, modification, and duplication of an LTR40a element within the locus.
Given the presence of LTR40a elements within the KLK loci of diverse species, the first LTR40a element seems to have inserted into the KLK locus during the divergence of eutherian mammals. The internal duplication that created Duplicate 1 must have occurred before, or soon after, this insertion, because it is present in all fulllength copies of the LTR in all species. It is likely that the original LTR40a element was further copied through larger duplications, often with adjacent KLK genes. This is consistent with the centromeric end of the KLK locus 
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having undergone dramatic changes during mammalian evolution. In this region, a duplication of KLK2, and it would seem its adjacent LTR40a element, created KLK3 in primates. In contrast, KLK2 and the LTR are absent in the cow and replaced by 23 extra KLK genes in the mouse and 27 in the rat (38 -40). Indeed, it is striking how the fate of the LTR40a element and prostatic KLK genes are linked. When the LTR40a element is missing or mutated, KLK2 is a pseudogene, for example in the gorilla, rhesus macaque, cotton top tamarin, rat, and mouse (32, 41). This suggests that the tissue-specific expression profiles and physiological functions of prostatic KLK proteins are intertwined. As proteases, the major physiological function of KLK2 and KLK3 is to cleave seminogelins, the gel-forming proteins in ejaculate, which liquefies the seminal clot and increases sperm motility (42, 43). This process would be altered without the LTR40a elements promoting high levels of KLK2 and KLK3 expression in prostate epithelial cells. Indeed, evolutionary changes in KLK proteins, seminogelins, and other ejaculatory factors are associated with differences in copulatory plug formation and promiscuity between species (41, 44). Thus, the exaptation of LTR40a elements into the KLK locus has had important consequences for mammalian reproductive biology. It has been speculated that shared enhancers may jointly regulate multiple KLK genes, because the genes are often coexpressed in various tissues. For example, a suite of KLK genes are all up-regulated by estradiol in breast cancer cell lines (45). However, given that the KLK locus evolved through a series of duplications, an alternative explanation is that KLK genes are concurrently expressed but independently regulated by conserved regulatory elements. Kroon et al. (46) came to this conclusion, when they showed that different fragments of the rat KLK locus maintain their correct tissue-specific expression profile in the submandibular gland of transgenic mice. Our data also support the notion that KLK genes have autonomous, rather than shared, enhancers, because separate LTR40a-derived enhancers accompany prostate-expressed KLK genes in humans and other mammals.
The novel KLKP1-T LTR40a element is the first region in the KLK locus outside of KLK2 and KLK3 to be shown to directly bind the AR in prostate epithelial cells. In the process of characterizing this element using deletion constructs, we also demonstrated that it contains a functional ARE with a highly similar sequence to KLK3 AREIII and KLK2 AREII. However, the mere presence of an LTR40a element does not necessarily mean that an adjacent gene will be androgen regulated. ChIP assays showed that the KLK15 LTR40a element recruits the AR. However, it was insufficient for androgen responsiveness in luciferase assays. This element may either require coactivators not present in prostate cells or interaction with other binding sites within the KLK15 promoter, much like the looping of the KLK3 enhancer to its proximal promoter (14) . Similarly, the moderate responsiveness of the KLK2 LTR40a reporter construct, compared with the large fold changes in endogenous KLK2 gene expression, is probably due to the lack of the proximal promoter ARE within the construct. We also showed that the internal duplication of the LTR40a element is crucial for maximal androgen responsiveness. This region not only contains AREIII but binding sites for FoxA1 and GATA2, two important collaborating transcription factors that aid recruitment of the AR in prostate epithelial cells (10 -12, 15) . Thus, it seems that the overall effect of this duplication was to create a highly prostate-specific enhancer.
Like LTR40a, other LTR stimulate gene expression in hormone-dependent or reproductive tissues, especially the placenta and testes (35, 47). It is posited that so many LTR are hormone responsive because retroviruses are more likely to be inherited when they are expressed in germ cells (35). Furthermore, several LTR are also known to directly recruit the AR in prostate epithelial cells. For example, Goering et al. (48) recently showed that the LTR of the HERV-K_22q11.23 and HERVK17 human endogenous retroviruses recruit the AR and stimulate androgen-regulated expression of viral transcripts. Some exogenous retroviruses are also androgen-regulated in prostate epithelial cells. The glucocorticoid response element in the LTR of the mouse mammary tumor virus (MMTV) was one of the first hormone response elements to be identified (49). Because this element also binds the AR (50, 51), the MMTV LTR is often used as a reporter for AR signaling. The LTR of the xenotropic murine leukemia virus-related virus, which is controversially associated with prostate cancer, also has a hormone response element that mediates androgen-regulated gene expression (52, 53) . Several other viruses, including the Moloney murine leukemia virus, bovine leukemia virus, and Friend immunosuppressive virus, also have hormone response elements in their LTR and are regulated by glucocorticoids (54 -56) . LTR40a now joins this growing list of retroviral LTR that mediate hormone-dependent gene expression.
Ongoing studies are aiming to find new ways to target the AR in prostate cancer; but coincidentally, three of the most commonly used models of androgen responsiveness, KLK2, KLK3, and MMTV, all have enhancers derived from LTR. KLK2 and KLK3 are considered to be ideal models to study AR-regulated gene expression, because they are among the most highly expressed genes in prostate epithelial cells and are extremely sensitive to androgens. Both genes are very useful as simple read-outs of AR ac-tivity. However, they may not represent the complete spectrum of AR target genes for more complex mechanistic studies. This emphasizes the importance of using larger cohorts of reporter constructs or assessing general AR function using genome-wide techniques like ChIP-sequencing (30, 31).
Despite the notable examples of AR-regulated LTR, the proportion of androgen-responsive genes with LTR and other transposable elements as promoters and enhancers is currently unknown. Other hormone receptors are often recruited to transposable elements. For example, 19 -36% of estrogen receptor ␣ binding sites are within transposable elements, mostly Alu and mammalian interspersed repeat elements but also LTR (57) . Retinoic acid receptor binding sites are also commonly within Alu repeats (58) . By cross-referencing well-characterized AR-binding sites from the Androgen-Responsive Gene Database (59) with Repbase, we were able to identify several human and rodent genes that are regulated through repetitive elements (Supplemental Table 5 ). Many other genes also have repetitive elements that partly overlap known AR-binding regions (Supplemental Table 6 ). Like the KLK2 and KLK3 enhancers, most of these AR-binding sites were hitherto unrecognized as being within repetitive elements. An exception is the mouse sex-limited protein, which is well known to have three ARE within a nearby LTR1S4 element (60, 61) . The sequences of experimentally validated AR-binding sites closely resemble the consensus motif. However, this may be a historical artifact of previous investigators focusing on consensus-like sites (Supplemental Fig. 6 ). Nevertheless, these observations suggest that more AR-binding sites lie within transposable elements than was previously realized.
Although past studies on AR signaling tried to define global mechanisms underlying gene expression, the focus has shifted to defining distinct subclasses of target genes. A better understanding of the diversity of AR-binding regions will help predict differences in the AR transcriptional program between cell types and diseases. For example, AR target genes can be divided into groups where expression is lost, gained, or conserved (like KLK3) in response to changes in FoxA1 levels (62) . Given our results, we propose that target genes could also be subdivided based on whether their regulatory regions evolved from repetitive elements. One rationale for distinguishing this subset of genes is that repetitive elements, especially long interspersed nuclear elements-1 and Alu repeats, are CpG rich and normally heavily methylated. The loss of methylation of repetitive elements that occurs in prostate cancer (63) could therefore uncover a new class of responsive genes. Unfortunately, the full extent and consequences of AR binding within repetitive elements are currently unknown. This is partly due to the technical limitations of ChIP-chip, which usually involves repeatmasking, and ChIP-sequencing, where it is difficult to accurately map sequences to common repeats. Our data showing that KLK genes are regulated through repetitive elements make it a priority to determine the prevalence of AR-binding sites in repeats throughout the genome. As advances like paired-end and longer sequences make genome scale analyses of repetitive elements more feasible, it will be possible to determine whether repeats represent a distinct subset of AR-binding regions with different characteristics.
In summary, this study has demonstrated that androgen responsiveness of KLK3 and other KLK genes in prostate epithelial cells evolved through exaptation of a retroviral LTR. Given that KLK3 is the prototypical ARregulated target gene, further genome-wide studies into the role of repetitive elements in other AR-occupied regions are warranted.
